← FDA Drug Approvals (Drugs@FDA)
EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA LTD · Approved 2024-12-26
Drug application
- FDA Application #
ANDA212243- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- Generic name
- Empagliflozin
- Active ingredients
- EMPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- CIPLA LTD
- First approval
- 2024-12-26
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown